LB Pharmaceuticals is a drug development company focused on development treatments for CNS disorders. The company's lead compound is LB-102; a novel benzamide being developed the treatment of schizophrenia owned and development internally by LB. LB-102 recently completed a Phase 1 study; a First-in-... Read more
This company has no teams yet
Bristol-Myers Squibb
261 followers
Astellas Pharma
42 followers
NYU Langone Health
27 followers
West Pharmaceutical Services
8 followers
Curia Global
7 followers
AbbVie
279 followers
Navitus Health
4 followers
Xeris Pharmaceuticals
2 followers
Corcept Therapeutics
4 followers
Arthritis Knee Pain Centers
2 followers
Agiliti
7 followers
Explore companies